Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 106 articles:
HTML format
Text format



Single Articles


    March 2018
  1. DANIELSEN KV, Wiese S, Hove J, Bendtsen F, et al
    Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-5006.
    PubMed     Text format     Abstract available


    February 2018
  2. WEI M, Ford J, Li Q, Jeong D, et al
    Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-018-4964.
    PubMed     Text format     Abstract available


  3. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    PubMed     Text format     Abstract available


  4. MINDIKOGLU AL, Opekun AR, Mitch WE, Magder LS, et al
    Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Feb 1. pii: 10.1007/s10620-017-4897.
    PubMed     Text format     Abstract available


    January 2018
  5. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
    Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
    PubMed     Text format     Abstract available


  6. BURROUGHS TK, Wade JB, Ellwood MS, Fagan A, et al
    Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Dig Dis Sci. 2018 Jan 8. pii: 10.1007/s10620-017-4894.
    PubMed     Text format     Abstract available


    December 2017
  7. CHOE WH, Kim JH, Park JH, Kim HU, et al
    Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2017 Dec 27. pii: 10.1007/s10620-017-4814.
    PubMed     Text format     Abstract available


    November 2017
  8. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Text format     Abstract available


  9. CULLARO G, Kim G, Pereira MR, Brown RS Jr, et al
    Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4804.
    PubMed     Text format     Abstract available


  10. TANEJA S, Borkakoty A, Rathi S, Kumar V, et al
    Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease.
    Dig Dis Sci. 2017;62:3186-3192.
    PubMed     Text format     Abstract available


    October 2017
  11. KRUGER AJ, Mumtaz K, Anaizi A, Modi RM, et al
    Cirrhosis Is Associated with Increased Mortality in Patients with Diverticulitis: A Nationwide Cross-Sectional Study.
    Dig Dis Sci. 2017 Oct 6. doi: 10.1007/s10620-017-4782.
    PubMed     Text format     Abstract available


    September 2017
  12. LUTZ P, Goeser F, Kaczmarek DJ, Schlabe S, et al
    Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2017;62:2558-2568.
    PubMed     Text format     Abstract available


    August 2017
  13. XU H, Xiong J, Xu J, Li S, et al
    Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4704.
    PubMed     Text format     Abstract available


  14. LEE HW, Kim BK, Kim SU, Park JY, et al
    Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2017;62:2150-2158.
    PubMed     Text format     Abstract available


    June 2017
  15. AFSARI A, Lee E, Shokrani B, Boortalary T, et al
    Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Jun 13. doi: 10.1007/s10620-017-4626.
    PubMed     Text format     Abstract available


    May 2017
  16. PANTHAM G, Post A, Venkat D, Einstadter D, et al
    A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.
    Dig Dis Sci. 2017 May 30. doi: 10.1007/s10620-017-4630.
    PubMed     Text format     Abstract available


  17. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    PubMed     Text format     Abstract available


    April 2017
  18. DEVER JB, Ducom JH, Ma A, Nguyen J, et al
    Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.
    Dig Dis Sci. 2017 Apr 4. doi: 10.1007/s10620-017-4548.
    PubMed     Text format     Abstract available


  19. YOSHIDA T, Akiba J, Matsui T, Nakamura K, et al
    Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4550.
    PubMed     Text format     Abstract available


    March 2017
  20. PATIDAR KR, Thacker LR, Wade JB, White MB, et al
    Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.
    Dig Dis Sci. 2017 Mar 3. doi: 10.1007/s10620-017-4509.
    PubMed     Text format     Abstract available


  21. KALAFATELI M, Zisimopoulos K, Vourli G, Rigamonti C, et al
    Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.
    Dig Dis Sci. 2017 Mar 1. doi: 10.1007/s10620-017-4504.
    PubMed     Text format     Abstract available


  22. O'LEARY JG, Wong F, Reddy KR, Garcia-Tsao G, et al
    Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience.
    Dig Dis Sci. 2017;62:768-776.
    PubMed     Text format     Abstract available


    February 2017
  23. CAI CX, Buddha H, Castelino-Prabhu S, Zhang Z, et al
    Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2017 Feb 13. doi: 10.1007/s10620-017-4470.
    PubMed     Text format     Abstract available


  24. KIM G, Huh JH, Lee KJ, Kim MY, et al
    Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017 Feb 7. doi: 10.1007/s10620-017-4471.
    PubMed     Text format     Abstract available


    January 2017
  25. HUNG TH, Tseng CW, Tsai CC, Hsieh YH, et al
    Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion.
    Dig Dis Sci. 2017 Jan 27. doi: 10.1007/s10620-017-4463.
    PubMed     Text format     Abstract available


  26. ZHAO D, Luo Y, Xia Y, Zhang JJ, et al
    MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis.
    Dig Dis Sci. 2017 Jan 12. doi: 10.1007/s10620-016-4411.
    PubMed     Text format     Abstract available


  27. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Text format     Abstract available


  28. DELLA-GUARDIA B, Evangelista AS, Felga GE, Marins LV, et al
    Diagnostic Accuracy of Transient Elastography for Detecting Liver Fibrosis After Liver Trannsplantation: A Specific Cut-Off Value Is Really Needed?
    Dig Dis Sci. 2017;62:264-272.
    PubMed     Text format     Abstract available


    December 2016
  29. NARDELLI S, Allampati S, Riggio O, Mullen KD, et al
    Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.
    Dig Dis Sci. 2016 Dec 30. doi: 10.1007/s10620-016-4425.
    PubMed     Text format     Abstract available


  30. KIM EJ, Yeon JE, Kwon OS, Lee HN, et al
    Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4431.
    PubMed     Text format     Abstract available


  31. GOOSSENS N, Breguet R, De Vito C, Terraz S, et al
    Peribiliary Gland Dilatation in Cirrhosis: Relationship with Liver Failure and Stem Cell/Proliferation Markers.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4421.
    PubMed     Text format     Abstract available


    November 2016
  32. HWANG GL, Sze DY
    Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  33. WALLING AM, Ahluwalia SC, Wenger NS, Booth M, et al
    Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    October 2016
  34. TSOU YK, Liu CY, Fu KI, Lin CH, et al
    Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    September 2016
  35. ALLEGRETTI AS, Ortiz G, Kalim S, Wibecan J, et al
    Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  36. DONG T, Aronsohn A, Gautham Reddy K, Te HS, et al
    Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  37. NATARAJAN Y, White DL, El-Serag HB, Ramsey D, et al
    Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    August 2016
  38. HOEFS JC
    Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?
    Dig Dis Sci. 2016.
    PubMed     Text format    


  39. LIU TL, Trogdon J, Weinberger M, Fried B, et al
    Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    July 2016
  40. HOU F, Qi X, Guo X
    Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  41. MONTANO-LOZA AJ, Thandassery RB, Czaja AJ
    Targeting Hepatic Fibrosis in Autoimmune Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  42. KIM JH, Sinn DH, Kim K, Kang W, et al
    Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  43. HEGADE VS, Khanna A, Walker LJ, Wong LL, et al
    Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  44. KAPLAN DE, Dai F, Skanderson M, Aytaman A, et al
    Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    June 2016
  45. SCLAIR SN, Carrasquillo O, Czul F, Trivella JP, et al
    Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  46. CAMUS M, Khungar V, Jensen DM, Ohning GV, et al
    Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  47. DE LUCA-JOHNSON J, Wangensteen KJ, Hanson J, Krawitt E, et al
    Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  48. THOMAS E, Schiff ER
    Early Detection of Steatohepatitis: Less Teeth NASHing and More Research?
    Dig Dis Sci. 2016.
    PubMed     Text format    


    May 2016
  49. ASCHA M, Hanouneh M, S Ascha M, Zein NN, et al
    Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease >/=15.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  50. KASWALA DH, Lai M, Afdhal NH
    Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
    Dig Dis Sci. 2016;61:1356-64.
    PubMed     Text format     Abstract available


  51. GOH GB, McCullough AJ
    Natural History of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1226-33.
    PubMed     Text format     Abstract available


  52. ABDOU RM, Zhu L, Baker RD, Baker SS, et al
    Gut Microbiota of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1268-81.
    PubMed     Text format     Abstract available


    April 2016
  53. MENDEL I, Yacov N, Shoham A, Ishai E, et al
    Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  54. COZEN ML, Ryan JC, Shen H, Cheung R, et al
    Improved Survival Among all Interferon-alpha-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  55. BRUNS T, Reuken PA, Stengel S, Gerber L, et al
    NOD2 Risk Variants and Pathological Bacterial Translocation in Decompensated Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  56. TAN HK, James PD, Wong F
    Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  57. PECTASIDES E, Miksad R, Pyatibrat S, Srivastava A, et al
    Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    March 2016
  58. SARGENTI K, Johansson A, Bertilsson S, Mattsby-Baltzer I, et al
    Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  59. VUPPALANCHI R, Chalasani N
    Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  60. NAGPAL SJ, Kabbany MN, Mohamad B, Lopez R, et al
    Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  61. THOMSON M, Konerman MA, Choxi H, Lok AS, et al
    Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  62. CHO SB, Choi YH, So YH, Ahn DW, et al
    Balloon-Occluded Retrograde Transvenous Obliteration of Jejunal Varices: A Case Report, Therapeutic Approach.
    Dig Dis Sci. 2016;61:948-51.
    PubMed     Text format    


  63. PIMENTEL CF, Jiang ZG, Otsubo T, Feldbrugge L, et al
    Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
    Dig Dis Sci. 2016;61:905-12.
    PubMed     Text format     Abstract available


    February 2016
  64. CHEN L, Guo YZ, Li AD, Ma JJ, et al
    Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    January 2016
  65. PATEL YA, Berg CL, Moylan CA
    Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  66. LANDIS CS, Ghabril M, Rustgi V, Di Bisceglie AM, et al
    Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  67. INTAGLIATA NM, Henry ZH, Maitland H, Shah NL, et al
    Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  68. BORHOFEN SM, Gerner C, Lehmann J, Fimmers R, et al
    The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  69. HA J, Hendrix M, Guyer AG
    Microwave Ablation for the Treatment of Hypersplenism: Short Waves, Low Cost, Big Results.
    Dig Dis Sci. 2016;61:6-7.
    PubMed     Text format    


  70. FLEMMING JA, Saxena V, Shen H, Terrault NA, et al
    Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.
    Dig Dis Sci. 2016;61:62-9.
    PubMed     Text format     Abstract available


    December 2015
  71. AN J, Zheng L, Xie S, Yin F, et al
    Regulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    November 2015
  72. PETERSEN J, Heyne R, Mauss S, Schlaak J, et al
    Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  73. PARK CH, Han DS, Jeong JY, Eun CS, et al
    Outcomes of Propofol Sedation During Emergency Endoscopy Performed for Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  74. ROGAL SS, Yan P, Rimland D, Re VL 3rd, et al
    Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    October 2015
  75. POP A, Procopet B, Stefanescu H, Cavasi A, et al
    Clostridium Difficile Screening in Cirrhosis: One for All, or Some for One?
    Dig Dis Sci. 2015.
    PubMed     Text format    


    September 2015
  76. MACHADO MV, Kruger L, Jewell ML, Michelotti GA, et al
    Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  77. RUNYON B, Mitroi L
    Do Automated Telephone Systems Decrease Hospital Readmissions Among Patients with Cirrhosis?
    Dig Dis Sci. 2015.
    PubMed     Text format    


    August 2015
  78. MANGRAY S, Zweit J, Puri P
    Zinc Deficiency in Cirrhosis: Micronutrient for Thought?
    Dig Dis Sci. 2015.
    PubMed     Text format    


  79. PERUMPAIL RB, Wong RJ, Ahmed A, Harrison SA, et al
    Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    July 2015
  80. VINDIGNI SM, Surawicz CM
    Cirrhosis and C. difficile: A Deadly Duo?
    Dig Dis Sci. 2015.
    PubMed     Text format    


  81. MINDIKOGLU AL, Dowling TC, Schaub DJ, Hutson WR, et al
    Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  82. NIELSEN MJ, Lehmann J, Leeming DJ, Schierwagen R, et al
    Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  83. DYAL HK, Aguilar M, Bhuket T, Liu B, et al
    Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  84. XUE Y, Michalopoulos G
    Tregs: A Therapeutic Target for the Treatment of Portal Fibrosis?
    Dig Dis Sci. 2015;60:1878-80.
    PubMed     Text format    


  85. JUAREZ-HERNANDEZ E, Uribe-Ramos MH, Ramos-Ostos MH, Lopez-Ramirez AY, et al
    Factors Associated with the Quality of Transient Elastography.
    Dig Dis Sci. 2015;60:2177-82.
    PubMed     Text format     Abstract available


  86. JOHNSON KB, Mueller JL, Simon TG, Zheng H, et al
    Reduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes.
    Dig Dis Sci. 2015;60:2190-5.
    PubMed     Text format     Abstract available


  87. WANG Q, Wen R, Lin Q, Wang N, et al
    Wogonoside Shows Antifibrotic Effects in an Experimental Regression Model of Hepatic Fibrosis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    June 2015
  88. CASADO JL, Esteban MA, Banon S, Moreno A, et al
    Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  89. MOLLER S, Bendtsen F
    Cirrhotic Multiorgan Syndrome.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  90. THOMSON M, Volk M, Kim HM, Piette JD, et al
    An Automated Telephone Monitoring System to Identify Patients with Cirrhosis at Risk of Re-hospitalization.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  91. JIANG X, Gao F, Ma Y, Feng S, et al
    Percutaneous Microwave Ablation in the Spleen for Treatment of Hypersplenism in Cirrhosis Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  92. GOH GB, Pagadala MR, Dasarathy J, Unalp-Arida A, et al
    Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.
    Dig Dis Sci. 2015;60:1825-31.
    PubMed     Text format     Abstract available


    May 2015
  93. CZAJA AJ
    Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  94. DEFILIPPIS EM, Kumar S
    Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  95. SAAB S, Alper T, Sernas E, Pruthi P, et al
    Hospitalized Patients with Cirrhosis Should Be Screened for Clostridium difficile Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  96. FOX RK
    Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  97. LUTZ HH, Schroeter B, Kroy DC, Neumann U, et al
    Doppler Ultrasound and Transient Elastography in Liver Transplant Patients for Noninvasive Evaluation of Liver Fibrosis in Comparison with Histology: A Prospective Observational Study.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    April 2015
  98. LUO F, Ishigami M, Achiwa K, Ishizu Y, et al
    Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  99. COREY KE, Misdraji J, Gelrud L, King LY, et al
    Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    February 2015
  100. LU CH, Hou QR, Deng LF, Fei C, et al
    MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    January 2015
  101. WONG VW, Lampertico P, de Ledinghen V, Chang PE, et al
    Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    December 2014
  102. MANSOOR S, Yerian L, Kohli R, Xanthakos S, et al
    The Evaluation of Hepatic Fibrosis Scores in Children with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


  103. TANG Y
    Curcumin Targets Multiple Pathways to Halt Hepatic Stellate Cell Activation: Updated Mechanisms In Vitro and In Vivo.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


    November 2014
  104. ZHANG K, Jiang L, Jia Z, Zhang Y, et al
    Radiofrequency Ablation Plus Devascularization Is the Preferred Treatment of Hepatocellular Carcinoma with Esophageal Varices.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


  105. ROH YS, Park S, Lim CW, Kim B, et al
    Depletion of Foxp3+ Regulatory T Cells Promotes Profibrogenic Milieu of Cholestasis-Induced Liver Injury.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


  106. BORZIO M, Dionigi E, Rossini A, Toldi A, et al
    Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field Experience.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: